GlassScriptPhysician profile
Jessie Black
NPI 1740903681
$875.67
in general payments reported to CMS, 2019-2025
12 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $509 · 2024: $126 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $459.95 | 2023-2025 | Farxiga, Lokelma |
| Calliditas Therapeutics US INC. | $181.12 | 2023-2025 | Tarpeyo |
| Amgen INC. | $38.83 | 2024-2025 | Tavneos, Krystexxa |
| Horizon Therapeutics Plc | $37.34 | 2023 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $30.92 | 2023-2025 | Ultomiris |
| Akebia Therapeutics INC | $24.98 | 2024 | Vafseo, Auryxia |
| Mozarc Medical US LLC | $23.26 | 2025 | Palindrome |
| Alnylam Pharmaceuticals INC. | $19.93 | 2023 | Oxlumo |
| Apellis Pharmaceuticals, INC. | $16.82 | 2025 | Empaveli |
| Travere Therapeutics, INC. | $14.60 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $14.59 | 2025 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $13.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessie Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.